Value of Head and Neck 4D-CTA Combined with SDF-1a/CXCR4 Signaling Pathway in Assessing the Risk of Ruptured Intracranial Posterior Communicating Aneurysms
-
摘要:
目的 探讨利用4D-CTA结合SDF-1a／CXCR4 信号通路评估颅内后交通动脉瘤破裂风险的价值。 方法 将 50 名未破裂颅内前交通动脉瘤患者和 50 名破裂颅内前交通动脉瘤患者分为未破裂组 1 和破裂组 1。所有患者均接受 4D-CTA 检查并检测血清SDF-1a水平。非破裂组 1 接受了 12 个月的随访后把后脉瘤破裂的患者被纳入破裂组 2，动脉瘤未破裂的患者被纳入非破裂组 2。 结果 诊断颅内后交通动脉瘤破裂的 Wn、AR、L、SR、SDF-1a 及其组合的 AUC 值均大于 0.70。破裂组 2 Wn、AR、L、SR和SDF-1a及其组合预测颅内后交通动脉瘤破裂的AUC值均大于0.70。 结论 4D-CTA 联合SDF-1a能有效区分破裂的颅内后交通动脉瘤并预测破裂风险。 -
关键词:
- 4D-CTA /
- 基质细胞衍生因子-1 /
- 颅内后交通动脉瘤破裂
Abstract:Objective To investigate the value of 4D-CTA combined with SDF-1a/CXCR4 signaling pathway in evaluating the risk of intracranial aneurysm rupture. Methods Fifty patients with unruptured intracranial posterior communicating aneurysms and 50 patients with ruptured intracranial posterior communicating aneurysms were divided into unruptured group 1 and ruptured group 1. All patients underwent 4D-CTA examination and serumSDF-1alevel was detected. Non-ruptured group 1 was followed up for 12 months（After conservative treatment）, on this basis, patients with ruptured posterior communicating aneurysms were included in ruptured group 2, and patients with unruptured posterior communicating aneurysms were included in non-ruptured group 2. Results The AUC values of Wn, AR, L, SR, SDF-1a and their combinations in diagnosing ruptured intracranial posterior communicating aneurysms were all greater than 0.70.The AUC values of Wn, AR, L, SR, SDF-1a and their combinations in predicting ruptured intracranial posterior communicating aneurysms in ruptured group 2 were all greater than 0.70. Conclusion 4D-CTA combined with SDF-1acan effectively distinguish ruptured intracranial posterior communicating aneurysms and predict the risk of rupture. -
Key words:
- 4D-CTA /
- SDF-1a /
- Ruptured posterior intracranial communicating aneurysm
-
图 3 AR、SR 及 VOR 数值 测量图示并动脉瘤基底部见异常搏动点（黄箭头所示）
Figure 3. Diagram of 4D measurement of AR，SR，and VOR values（shown by yellow arrow）
图 4 4D-CTA成像 后交通动脉异常搏动点（绿箭头）
Figure 4. Abnormal pulse points of Traffic artery after 4D-CTA （green arrow）
图 5 4D-CTA联合SDF-1对颅内后交通动脉瘤破裂的诊断价值
Figure 5. Diagnostic value of 4D-CTA combined with SDF-1 in the rupture of intracranial posterior communicating aneurysms
图 6 4D-CTA联合SDF-1对颅内后交通动脉瘤破裂的预测价值
Figure 6. Predictive value of 4D-CTA combined with SDF-1 for ruptured intracranial aneurysms
表 1 破裂组1和非破裂组1 SDF-1对比[μg/L，（$\bar x \pm s $）]
Table 1. Comparison of SDF-1 between unruptured group 1 and ruptured group 1 [μg/L，（$\bar x \pm s $）]
组别 SDF-1 破裂组 1 （n=50） 135.03±11.01 非破裂 1 （n=50） 149.48±13.22 T 5.900 P <0.001* *P<0.05。 
下载: 导出CSV
表 2 4D-CTA联合SDF-1对颅内后交通动脉瘤破裂的诊断价值
Table 2. Diagnostic value of 4D-CTA combined with SDF-1 in the rupture of intracranial posterior communicating aneurysms.
因素 AUC 临界值 95%CI P 特性异 敏感性 Wn 0.844 2.990 0.765～0.923 <0.001* 0.760 0.860 AR 0.888 1.115 0.818～0.958 <0.001* 0.840 0.900 L 0.834 4.585 0.758～0.909 <0.001* 0.660 0.820 SR 0.771 1.255 0.679～0.863 <0.001* 0.680 0.740 SDF-1 0.800 141.155 0.712～0.887 <0.001* 0.760 0.760 Combination 0.976 0.953～0.999 <0.001* 0.880 0.960 *P<0.05。
下载: 导出CSV
表 3 破裂组2和非破裂组2 SDF-1对比[μg/L，（$\bar x \pm s $）]
Table 3. Comparison of SDF-1 between unruptured group 2 and ruptured group 2 [μg/L，（$\bar x \pm s $）]
组别 SDF-1 破裂组2 （n=19） 142.38±11.22 非破裂2 （n=31） 128.13±10.22 t 4.660 P <0.001* *P<0.05。
下载: 导出CSV
表 4 联合SDF-1对颅内后交通动脉瘤破裂的预测价值
Table 4. Predictive value of combined SDF-1 for rupture of intracranial posterior communicating aneurysms
因素 AUC 临界值 95%CI P 特性异 敏感性 Wn 0.926 2.710 0.856～0.996 <0.001* 0.871 0.842 AR 0.705 1.065 0.546～0.863 0.016 0.710 0.632 L 0.744 4.215 0.579～0.910 0.004 0.742 0.737 SR 0.792 1.115 0.652～0.932 0.001 0.645 0.789 SDF-1 0.847 133.510 0.742～0.952 <0.001* 0.710 0.789 Combination 0.973 − 0.928～1.000 <0.001* 0.903 0.947 *P<0.05。
下载: 导出CSV
-
[1] Adeeb N,Griessenauer C J,Dmytriw A A,et al. Risk of branch occlusion and ischemic complications with the pipeline embolization device in the treatment of posterior circulation aneurysms[J]. AJNR Am J Neuroradiol,2018,39(7):1303-1309. doi: 10.3174/ajnr.A5696 [2] Cao R,Jiang Y,Li L,et al. Venous collaterals in acute ischemic stroke patients after endovascular treatments: a novel scoring system using 4D computed tomography angiography[J]. Quant Imaging Med Surg,2022,12(11):5030-5043. doi: 10.21037/qims-22-245 [3] Liu S, Wang Y N, Ma B, et al . Gingipain-responsive thermosensitive hydrogel loaded with SDF-1 facilitates in situ periodontal tissue regeneration[J]. ACS Appl Mater Interfaces, 2021, 13（31）: 368 80-36893. [4] Shi J,Yang Y,Yin N,et al. Engineering CXCL12 biomimetic decoy-integrated versatile immunosuppressive nanoparticle for ischemic stroke therapy with management of overactivated brain Immune microenvironment[J]. Small Methods,2022,6(1):e2101158. doi: 10.1002/smtd.202101158 [5] 徐鹏,陈英,施小燕,等. 3D-CTA 对颅内后循环出血性动脉瘤早期诊断的价值[J]. 中华急诊医学杂志,2020,29(1):127-131. [6] Hallikainen J,Keränen S,Savolainen J,et al. Role of oral pathogens in the pathogenesis of intracranial aneurysm: review of existing evidence and potential mechanisms[J]. Neurosurg Rev,2021,44(1):239-247. doi: 10.1007/s10143-020-01253-y [7] Sahnoun M, Soize S, Manceau P F, et al Intracranial aneurysm treatment with WEB and adjunctive stent: preliminary evaluation in a single-center series[J]. J Neurointerv Surg 2022 , 14（2）: 164-168. [8] Isoda R,Kanaoka Y,Watanabe T,et al. Total debranching plus antegrade thoracic endovascular aortic repair without side clamping in a patient with arch aneurysm and ascending aorta calcification[J]. Ann Vasc Dis,2021,14(2):181-184. doi: 10.3400/avd.cr.21-00035 [9] Saiga A,Koizumi J,Osumi K,et al. Celiac artery dissection and retroperitoneal hemorrhage in median arcuate ligament syndrome treated with a stent and transcatheter arterial embolization: Preprocedural 4-dimensional computed tomography angiography assessment[J]. Vasc Endovascular Surg,2022,56(1):75-79. doi: 10.1177/15385744211028738 [10] Zhang J,Li X,Zhao B,et al. Irregular pulsation of aneurysmal wall is associated with symptomatic and ruptured intracranial aneurysms[J]. J Neurointerv Surg,2023,15(1):91-96. doi: 10.1136/neurintsurg-2021-018381 [11] De Paepe M E,Wong T,Chu S,et al. Stromal cell-derived factor-1 (SDF-1) expression in very preterm human lungs: Potential relevance for stem cell therapy for broncho pulmonary dysplasia[J]. Exp Lung Res,2020,46(5):146-156. doi: 10.1080/01902148.2020.1751899 [12] Jiang C, Li R, Ma X, et al. AMD3100 and SDF-1 regulate cellular functions of endothelial progenitor cells and accelerate endothelial regeneration in a rat carotid artery injury model[J]. Mol Med Rep, 2020 , 22（4）: 3201-3212. [13] Newberry J,Desai S,Adler C,et al. SDF-1 preconditioned HPC scaffolds mobilize cartilage-derived progenitors and stimulate meniscal fibrocartilage repair in human explant tissue culture[J]. Connect Tissue Res,2020,61(3-4):338-348. doi: 10.1080/03008207.2019.1689966 [14] Postnov A,Suslov A,Sobenin I,et al. Thoracic aortic aneurysm: Blood pressure and inflammation as key factors in the development of aneurysm dissection[J]. Curr Pharm Des,2021,27(28):3122-3127. doi: 10.2174/1381612827666210210142200 [15] Edwin K Jackson,Delbert G Gillwepie,Stenan P Tofovic,et al. DPP4 Inhibition,NPY1-36,PYY1-36,SDF-1 α,and a hypertensive genetic background conspire to augment cell proliferation and collagen production: Effects that are abolished by low concentrations of 2-methoxyestradiol pharmacol exp ther[J]. Journal of Pharmacology & Experimental Therapeutics,2020,373(1):135-148. -
点击查看大图
计量
- 文章访问数: 721
- HTML全文浏览量: 847
- PDF下载量: 13
- 被引次数: 0
